bioAffinity Technologies, Inc. Interest Expense
bioAffinity Technologies, Inc. (BIAF) reported Interest Expense of $23.55 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-15
- bioAffinity Technologies, Inc. interest expense for the quarter ending 2024-03-31 was $23.55K, a 1322.96% increase year-over-year.
- bioAffinity Technologies, Inc. interest expense for the quarter ending 2023-12-31 was $25.32K, a 71.64% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense for the quarter ending 2023-09-30 was $8.79K, a 99.02% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense for the quarter ending 2023-06-30 was $1.36K, a 99.66% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense for fiscal 2023 was $37.13K, a 98.53% decline from fiscal 2022.
- bioAffinity Technologies, Inc. interest expense for fiscal 2022 was $2.53M, a 152.80% increase from fiscal 2021.
- bioAffinity Technologies, Inc. interest expense for fiscal 2021 was $1.00M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | $23.55K 10-Q · filed 2024-05-15 | $48.87K derived: sum of 2 quarters · filed 2024-05-15 | $57.66K derived: sum of 3 quarters · filed 2024-05-15 | $59.02K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-12-31 | $25.32K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $34.11K derived: sum of 2 quarters · filed 2024-04-01 | $35.47K derived: sum of 3 quarters · filed 2024-04-01 | $37.13K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $8.79K 10-Q · filed 2023-11-14 | $10.14K derived: sum of 2 quarters · filed 2023-11-14 | $11.80K 10-Q · filed 2023-11-14 | $101.09K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-06-30 | $1.36K 10-Q · filed 2023-08-14 | $3.02K 10-Q · filed 2023-08-14 | $92.31K derived: sum of 3 quarters · filed 2024-05-15 | $988.81K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-03-31 | $1.66K 10-Q · filed 2024-05-15 | $90.94K derived: sum of 2 quarters · filed 2024-05-15 | $987.45K derived: sum of 3 quarters · filed 2024-05-15 | $1.39M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $89.29K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $985.79K derived: sum of 2 quarters · filed 2024-04-01 | $1.39M derived: sum of 3 quarters · filed 2024-04-01 | $2.53M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $896.50K 10-Q · filed 2023-11-14 | $889.09K 10-Q · filed 2022-11-14 | $1.30M derived: sum of 2 quarters · filed 2023-11-14 | $2.44M 10-Q · filed 2023-11-14 | $2.44M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $399.26K 10-Q · filed 2023-08-14 | $1.55M 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $638.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $773.38K derived: sum of 2 quarters · filed 2023-03-31 | $1.00M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $135.36K 10-Q · filed 2022-11-14 | $363.83K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |